Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

428 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmaceutical Equivalence of Distributed Generic Antiretroviral (ARV) in Asian Settings: The Cross-Sectional Surveillance Study - PEDA Study.
Sapsirisavat V, Vongsutilers V, Thammajaruk N, Pussadee K, Riyaten P, Kerr S, Avihingsanon A, Phanuphak P, Ruxrungtham K; PEDA study team. Sapsirisavat V, et al. Among authors: phanuphak p. PLoS One. 2016 Jun 20;11(6):e0157039. doi: 10.1371/journal.pone.0157039. eCollection 2016. PLoS One. 2016. PMID: 27322409 Free PMC article.
Neither branded nor generic lopinavir/ritonavir produces adequate lopinavir concentrations at a reduced dose of 200/50 mg twice daily.
Ramautarsing RA, van der Lugt J, Gorowara M, Wongsabut J, Khongpetch C, Phanuphak P, Ananworanich J, Lange JM, Burger DM, Ruxrungtham K, Avihingsanon A. Ramautarsing RA, et al. Among authors: phanuphak p. J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):55-8. doi: 10.1097/QAI.0b013e31823ba736. J Acquir Immune Defic Syndr. 2012. PMID: 22027875 Clinical Trial.
Low-dose versus standard-dose ritonavir-boosted atazanavir in virologically suppressed Thai adults with HIV (LASA): a randomised, open-label, non-inferiority trial.
Bunupuradah T, Kiertiburanakul S, Avihingsanon A, Chetchotisakd P, Techapornroong M, Leerattanapetch N, Kantipong P, Bowonwatanuwong C, Banchongkit S, Klinbuayaem V, Mekviwattanawong S, Nimitvilai S, Jirajariyavej S, Prasithsirikul W, Munsakul W, Bhakeecheep S, Chaivooth S, Phanuphak P, Cooper DA, Apornpong T, Kerr SJ, Emery S, Ruxrungtham K; LASA Study Group. Bunupuradah T, et al. Among authors: phanuphak p. Lancet HIV. 2016 Aug;3(8):e343-e350. doi: 10.1016/S2352-3018(16)30010-8. Epub 2016 May 24. Lancet HIV. 2016. PMID: 27470026 Clinical Trial.
Antiretroviral-naïve HIV-infected patients had lower bone formation markers than HIV-uninfected adults.
Wattanachanya L, Jantrapakde J, Avihingsanon A, Ramautarsing R, Kerr S, Trachunthong D, Pussadee K, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, Phanuphak N, Sunthornyothin S, Phanuphak P; TNT 003 study team. Wattanachanya L, et al. Among authors: phanuphak p, phanuphak n. AIDS Care. 2020 Aug;32(8):984-993. doi: 10.1080/09540121.2019.1622631. Epub 2019 May 28. AIDS Care. 2020. PMID: 31137948
Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
Han WM, Wattanachanya L, Apornpong T, Jantrapakde J, Avihingsanon A, Kerr SJ, Teeratakulpisarn N, Jadwattanakul T, Chaiwatanarat T, Buranasupkajorn P, Ramautarsing R, Phanuphak N, Sunthornyothin S, Ruxrungtham K, Phanuphak P; TNT 003.1 study team. Han WM, et al. Among authors: phanuphak p, phanuphak n. PLoS One. 2020 Mar 25;15(3):e0230368. doi: 10.1371/journal.pone.0230368. eCollection 2020. PLoS One. 2020. PMID: 32210458 Free PMC article.
HIV/AIDS in Asia.
Ruxrungtham K, Brown T, Phanuphak P. Ruxrungtham K, et al. Among authors: phanuphak p. Lancet. 2004 Jul 3-9;364(9428):69-82. doi: 10.1016/S0140-6736(04)16593-8. Lancet. 2004. PMID: 15234860 Review.
428 results